TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 6.81
-0.29 (-4.08%)
Jul 31, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 2.62 billion as of July 31, 2026. Its market cap has decreased by -68.46% in one year.
Market Cap
2.62B
Enterprise Value
2.38B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.81
ChartMarket Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 2.62B, a decrease of -48.44%. That is a compound annual growth rate of -28.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.62B | -47.43% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.19B |
| Jiangsu Recbio Technology | 3.10B |
| HJ Science | 2.98B |
| Shandong Boan Biotechnology | 2.92B |
| Beijing Luzhu Biotechnology | 2.78B |
| Viva Biotech Holdings | 2.70B |
| Antengene Corporation | 2.68B |
| Clover Biopharmaceuticals | 2.60B |